IMMUNE Pharmaceuticals' Oncology Subsidiary CYTOVIA Announces Additional Clinical Trial Results on the Efficacy of Ceplene in Combination with LowDose IL2 in Patients With Acute Myeloid Leukemia Recently Published in Leukemia a Leading Hemato

NEW YORK July 5 2017 PRNewswire Cytovia the oncology subsidiary of Immune Pharmaceuticals Inc. a clinical stage biopharmaceutical company NASDAQ IMNP "Immune" or the "Company" announced the publication of clinical trial results on the ...